Guest on Mar 30th, 2017
Blake currently serves as the CEO of Epharmix Inc., a health technology company that creates condition-specific digital interventions to help increase patient engagement and facilitate faster, more effective treatment. Epharmix, with a powerful team of scientists, developers and advisers, is positioned to bring pragmatic and proven value to the health care industry. Previously co-founded Betaversity, an education technology company and Arch Grants recipient, with 30 percent monthly growth of the educational institution client base. Prior to attending Washington University, his fascination with nuclear medicine led him to win the top prize of Intel’s International Science and Engineering Fair.